SuperbCrew, a business news website dedicated to covering innovative companies in the tech and business fields, recently interviewed Asymmetrex CEO James L. Sherley. Dr. Sherley discusses Asymmetrex’s background, his personal background, and the newly developed algorithms for rapid low cost counting of therapeutic tissue stem cells. “Together AlphaSTAR and Asymmetrex solve the 6 decades unsolved
“Like neutrinos. That’s right! Like neutrinos!” With the recent awarding of the 2015 Nobel Prize in Physics for the demonstration of neutrino transformations and mass, you would not expect these words to belong to a stem cell biologist. But they are exactly what James L. Sherley, founder and director of stem cell biotechnology start-up company
This interview was created ahead of the Predictive Toxicology Summit taking place in London from 16th – 18th February 2015. To find out more about this and other topics covered in this industry leading conference please download the event agenda here. To view as a PDF click here. Pharma IQ: What have been the major